These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 17667028

  • 1. Paclitaxel-eluting stents for the treatment of complex coronary lesions: immediate and 12-month results.
    Sheiban I, Ballari GP, Moretti C, Marra WG, Meliga E, Omedè P, Sciuto F, Trevi GP.
    J Cardiovasc Med (Hagerstown); 2007 Aug; 8(8):582-8. PubMed ID: 17667028
    [Abstract] [Full Text] [Related]

  • 2. One-year clinical results and total costs of drug-eluting stents implantation in multivessel coronary artery disease.
    Varani E, Balducelli M, Vecchi G, Aquilina M, Maresta A.
    J Cardiovasc Med (Hagerstown); 2007 Aug; 8(8):596-601. PubMed ID: 17667030
    [Abstract] [Full Text] [Related]

  • 3. Outcomes after differential use of drug-eluting stents in diabetic patients: 1-year results from the DES.DE (Drug-Eluting Stent.DEutschland) registry.
    Akin I, Bufe A, Eckardt L, Reinecke H, Richardt G, Kuck KH, Senges J, Schneider S, Nienaber CA, DES.DE Study Group.
    Catheter Cardiovasc Interv; 2010 Jul 01; 76(1):50-7. PubMed ID: 20578192
    [Abstract] [Full Text] [Related]

  • 4. Long-term paclitaxel-eluting stent outcomes in elderly patients.
    Forman DE, Cox DA, Ellis SG, Lasala JM, Ormiston JA, Stone GW, Turco MA, Wei JY, Joshi AA, Dawkins KD, Baim DS.
    Circ Cardiovasc Interv; 2009 Jun 01; 2(3):178-87. PubMed ID: 20031714
    [Abstract] [Full Text] [Related]

  • 5. Three-year follow-up of the first prospective randomized comparison between paclitaxel and sirolimus stents: the TAXi-LATE trial.
    Berger A, Stauffer JC, Seydoux C, Siegenthaler M, Benoît A, Goy JJ.
    Catheter Cardiovasc Interv; 2007 Aug 01; 70(2):163-6. PubMed ID: 17630653
    [Abstract] [Full Text] [Related]

  • 6. Unprotected left main disease managed with drug-eluting stents: long-term outcome of 100 patients with increased surgical risk.
    Wood FO, Saylors EK, Schneider JE, Jobe RL, Mann JT.
    Catheter Cardiovasc Interv; 2008 Mar 01; 71(4):533-8. PubMed ID: 18307224
    [Abstract] [Full Text] [Related]

  • 7. Impact of three or more sirolimus-eluting stents versus paclitaxel-eluting stents on clinical outcomes in patients undergoing percutaneous coronary intervention.
    Chu WW, Kuchulakanti PK, Torguson R, Wang B, Clavijo LC, Suddath WO, Pichard AD, Satler LF, Kent KM, Waksman R.
    Catheter Cardiovasc Interv; 2006 Jul 01; 68(1):62-6. PubMed ID: 16755592
    [Abstract] [Full Text] [Related]

  • 8. Randomized comparison of everolimus-eluting and paclitaxel-eluting stents: two-year clinical follow-up from the Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients with de novo Native Coronary Artery Lesions (SPIRIT) III trial.
    Stone GW, Midei M, Newman W, Sanz M, Hermiller JB, Williams J, Farhat N, Caputo R, Xenopoulos N, Applegate R, Gordon P, White RM, Sudhir K, Cutlip DE, Petersen JL, SPIRIT III Investigators.
    Circulation; 2009 Feb 10; 119(5):680-6. PubMed ID: 19171853
    [Abstract] [Full Text] [Related]

  • 9. Usage patterns and 2-year outcomes with the TAXUS express stent: results of the US ARRIVE 1 registry.
    Lasala JM, Cox DA, Dobies D, Muhlestein JB, Katopodis JN, Revtyak G, Baim DS, ARRIVE 1 Participating Physicians.
    Catheter Cardiovasc Interv; 2008 Oct 01; 72(4):433-45. PubMed ID: 18814217
    [Abstract] [Full Text] [Related]

  • 10. Long-term clinical outcomes after sirolimus-eluting stent implantation for treatment of restenosis within bare-metal versus drug-eluting stents.
    Whan Lee C, Kim SH, Suh J, Park DW, Lee SH, Kim YH, Hong MK, Kim JJ, Park SW, Park SJ.
    Catheter Cardiovasc Interv; 2008 Apr 01; 71(5):594-8. PubMed ID: 18311841
    [Abstract] [Full Text] [Related]

  • 11. In-hospital complications and long-term outcomes of the paclitaxel drug-eluting stent in acute ST-elevation myocardial infarction: a real-world experience from a high-volume medical center.
    Shammas NW, Shammas GA, Hahn A, Jerin M, Dippel EJ, Winter M.
    Cardiovasc Revasc Med; 2009 Apr 01; 10(3):151-5. PubMed ID: 19595395
    [Abstract] [Full Text] [Related]

  • 12. Complete versus incomplete revascularization in patients with multivessel disease undergoing percutaneous coronary intervention with drug-eluting stents.
    Tamburino C, Angiolillo DJ, Capranzano P, Dimopoulos K, La Manna A, Barbagallo R, Tagliareni F, Mangiafico S, Guzman LA, Galassi AR, Bass TA.
    Catheter Cardiovasc Interv; 2008 Oct 01; 72(4):448-56. PubMed ID: 18814218
    [Abstract] [Full Text] [Related]

  • 13. Drug-eluting stent thrombosis in routine clinical practice: two-year outcomes and predictors from the TAXUS ARRIVE registries.
    Lasala JM, Cox DA, Dobies D, Baran K, Bachinsky WB, Rogers EW, Breall JA, Lewis DH, Song A, Starzyk RM, Mascioli SR, Dawkins KD, Baim DS, ARRIVE 1 and ARRIVE 2 Participating Physicians.
    Circ Cardiovasc Interv; 2009 Aug 01; 2(4):285-93. PubMed ID: 20031730
    [Abstract] [Full Text] [Related]

  • 14. Long-term clinical effects of magnetic resonance imaging in patients with coronary artery stent implantation.
    Kaya MG, Okyay K, Yazici H, Sen N, Tavil Y, Turkoglu S, Timurkaynak T, Ozdemir M, Cemri M, Yalcin R, Cengel A.
    Coron Artery Dis; 2009 Mar 01; 20(2):138-42. PubMed ID: 19247183
    [Abstract] [Full Text] [Related]

  • 15. Long-term clinical outcomes of real-world experience using sirolimus-eluting stents in saphenous vein graft disease.
    Ramana RK, Ronan A, Cohoon K, Homan D, Sutherland J, Steen L, Liu J, Loeb H, Lewis BE.
    Catheter Cardiovasc Interv; 2008 Jun 01; 71(7):886-93. PubMed ID: 18412238
    [Abstract] [Full Text] [Related]

  • 16. Early outcome after paclitaxel-eluting stents in patients with acute and subacute myocardial infarction. A clinical study.
    Margheri M, Giglioli C, Comeglio M, Valente S, Chechi T, Falai M, Becherini R, Vittori G, Parigi E, Lazzeri C, Gensini GF.
    Ital Heart J; 2004 Jul 01; 5(7):536-40. PubMed ID: 15487272
    [Abstract] [Full Text] [Related]

  • 17. Outcomes after percutaneous coronary intervention of ostial lesions in the era of drug-eluting stents.
    Freeman M, Clark DJ, Andrianopoulos N, Duffy SJ, Lim HS, Brennan A, Charter K, Shaw J, Horrigan M, Ajani AE, Sebastian M, Reid CM, Farouque HM, Melbourne Interventional Group.
    Catheter Cardiovasc Interv; 2009 May 01; 73(6):763-8. PubMed ID: 19309731
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Clinical safety and efficacy of a novel thin-strut cobalt-chromium coronary stent system: results of the real world Coroflex Blue Registry.
    Bocksch W, Pomar F, Dziarmaga M, Tresukosol D, Ismail O, Janek B, Carlsson J, Simon JP, Coroflex Blue Registry Investigators.
    Catheter Cardiovasc Interv; 2010 Jan 01; 75(1):78-85. PubMed ID: 19739262
    [Abstract] [Full Text] [Related]

  • 20. Percutaneous coronary intervention utilizing a new endothelial progenitor cells antibody-coated stent: a prospective single-center registry in high-risk patients.
    Miglionico M, Patti G, D'Ambrosio A, Di Sciascio G.
    Catheter Cardiovasc Interv; 2008 Apr 01; 71(5):600-4. PubMed ID: 18360849
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.